Cagrilintide vs Liraglutide

Name: Cagrilintide vs Liraglutide
Published: 2026-10-24

Updated Oct 24, 20267 sources

Key differences

1In the phase 2 trial, cagrilintide 4.5 mg reached 10.8% at 26 weeks vs 9.0% on liraglutide 3.0 mg (trial product estimand).
2Cagrilintide is injected once a week; liraglutide is a daily GLP-1 injection.

Facts from each record, in the same words as their own pages.

Cagrilintide and Liraglutide side by side
	Cagrilintide	Liraglutide
Category	Weight loss	GLP-1, Weight loss
Evidence	Some human trials	Strong human trials
FDA status	In clinical trialsRegulatory	FDA approved as Victoza +1Regulatory
WADA	Not confirmed	Not prohibited
Half-life	About 7 to 8 days (159 to 195 hours). Levels peak 1 to 3 days after a dose. Measured at 0.16 to 4.5 mg alongside semaglutide.Clinical study	About 13 hours after an injection under the skin, which suits once-daily dosing.Regulatory
Routes	Subcutaneous injection	Subcutaneous injection
Forms	Not reported	Prefilled pen, Ready-to-use vial, Vial (powder)
Reported doses	0.1 to 4.5 mg (subcutaneous injection)	0.6 to 3 mg (subcutaneous injection)
Most cited frequency	Once weekly, added from week 9	Once daily; up 0.6 mg each week from 0.6 mg, then hold at 3 mg
Vial sizes	5 mg, 10 mgCompetitor guide	5 mg, 10 mg, 30 mgCompetitor guide
Mixed vial keeps	Keep the mixed vial at 2 to 8 °C, away from light, and use it within about 28 to 30 days.Community-reported	Keep a mixed research vial in the fridge and use it within 28 days, per guides.Competitor guide
Protocols on file	13	5

Doses shown are what sources report, labelled by origin. Not medical advice.

7 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.